069620.KS

Daewoong Pharmaceutical Co., Ltd | Cotação de Ações

Última atualização07/08/2025, 03:30:30

Preço₩ 134.400

Variação (dia)-₩ 2.000 (-1.47%)▼

Min. 52 Semanas₩ 109.000

Máx. 52 Semanas₩ 174.500

Capitalização de mercado--

Endereço: 12, Bongeunsa-ro 114-gil, Seoul, 135-715

Telefone: 82 2 550 8209

Funcionários: 1.644

DAEWOONG PHARM069620.KS

₩ 134.400

- 2.0001,5%

07/08/2025 03:30:30

1D 7D 1M 3M 1A Tudo

Visão geral da empresa

Preço atual₩ 134.400

Valor de mercado--

Abertura₩ 145.200

Preço máximo₩ 137.200

Preço mínimo₩ 133.600

Volume₩ 43 mil

Fechamento anterior₩ 136.400

Daewoong Pharmaceutical Co., Ltd. develops, manufactures and commercializes pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.develops, manufactures and commercializes pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.develops, manufactures and commercializes pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. Daewoong Pharmaceutical Co., Ltd. has a collaboration agreement with Salipro Biotech AB for the use of Salipro platform for stabilizing challenging membrane proteins to advance drug discovery. The company was founded in 1945 and is headquartered in Seoul, South Korea.

Ações relacionadas

Yuhan Corporation

000100.KS ▼2500.00% | ₩ 129.400

Hanmi Pharm. Co., Ltd.

128940.KS ▼1500.00% | ₩ 253.000

GC Biopharma Corp.

006280.KS ▼1100.00% | ₩ 144.500

Hanmi Science Co., Ltd.

008930.KS ▼100.00% | ₩ 28.750

Medy-Tox Inc.

086900.KQ ▲300.00% | ₩ 121.000

Assine nossa newsletter para receber atualizações gratuitas por e-mail

Mantenha-se informado assinando nossa newsletter. Receba atualizações gratuitas por e-mail, incluindo rendimentos, novidades do mercado e insights valiosos. Estamos comprometidos em fornecer informações relevantes diretamente à sua caixa de entrada.

Conheça os Planos e Preços personalizados para acessar recursos exclusivos

Explore nossos Planos e Preços para obter acesso a recursos exclusivos, atendendo às suas necessidades específicas. Oferecemos opções flexíveis para investidores de todos os níveis, garantindo que você tenha as ferramentas certas para otimizar sua estratégia de investimento.

Saiba mais sobre a brapi e nossa missão de fornecer informações confiáveis

Entenda a missão da brapi em fornecer informações estritamente informativas de fontes confiáveis. Valorizamos a transparência e a responsabilidade, incentivando investidores a buscar aconselhamento financeiro independente para decisões informadas.